Care of the Organ Donor

  • Younghoon Kwon
  • Marie R. Baldisseri


Since 1952 when the first kidney transplant was accomplished, nearly 400,000 transplantations have been performed with donors being from both deceased and living donors. However, almost 100,000 patients with end-stage organ failure remain on the United Network for Organ Sharing (UNOS) waiting list for organ transplantation.


Organ Donor Brain Death Pulmonary Capillary Wedge Pressure Organ Procurement Donation After Cardiac Death 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Sheehy E, Conrad SL, Brigham LE, et al. Estimating the number of potential organ donors in the United States. N Engl J Med. 2003;349:667–674.PubMedCrossRefGoogle Scholar
  2. 2.
    Jenkins DH, Reilly PM, Schwab CW. Improving the approach to organ donation: a review. World J Surg. 1999;23:644–649.PubMedCrossRefGoogle Scholar
  3. 3.
    Rosengard BR, Feng S, Alfrey EJ, et al. Report of the Crystal City meeting to maximize the use of donors recovered from the cadaver donor. Am J Transplant. 2002;2:701–711.PubMedCrossRefGoogle Scholar
  4. 4.
    Hunt SA, Baldwin J, Baumgartner W, et al. Cardiovascular management of a potential heart donor: a statement from the ­Transplantation Committee of the American College of Cardiology. Crit Care Med. 1996;24:1599–1601.PubMedCrossRefGoogle Scholar
  5. 5.
    Rosendale JD, Kauffman HM, McBride MA, et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation. 2003;75:1336–1341.PubMedCrossRefGoogle Scholar
  6. 6.
    Rosendale JD, Chabalewski FL, McBride MA, et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant. 2002;2:761–768.PubMedCrossRefGoogle Scholar
  7. 7.
    Schnuelle P, Berger S, de Boer J, et al. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation. 2001;72:455–463.PubMedCrossRefGoogle Scholar
  8. 8.
    Bhorade SM, Vigneswaran W, McCabe MA, et al. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000;19:1199–1204.PubMedCrossRefGoogle Scholar
  9. 9.
    Angel LF, Levine DJ, Restrepo MI, et al. Impact of a lung ­transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med. 2006;174:710–716.PubMedCrossRefGoogle Scholar
  10. 10.
    Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant. 1998;17:423–429.PubMedGoogle Scholar
  11. 11.
    Kuecuek O, Mantouvalou L, Klemz R, et al. Significant reduction of proinflammatory cytokines by treatment of the brain-dead donor. Transplant Proc. 2005;37:387–388.PubMedCrossRefGoogle Scholar
  12. 12.
    Rosendale JD, Kauffman HM, McBride MA, et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation. 2003;75:482–487.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Younghoon Kwon
    • 1
  • Marie R. Baldisseri
    • 2
  1. 1.HealthEast Care SystemSt. Joseph’s HospitalSaint PaulUSA
  2. 2.Department of Critical Care Medicine, University of PittsburghUniversity of Pittsburgh Medical CenterPittsburghUSA

Personalised recommendations